As of Sep 28
| +0.35 / +2.18%|
The 3 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 19.00, with a high estimate of 20.00 and a low estimate of 17.00. The median estimate represents a +15.92% increase from the last price of 16.39.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.